Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Regul Homeost Agents ; 31(1): 77-80, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28337873

RESUMO

Cyclosporine-A induces gingival overgrowth with disturbance in the homeostasis of cells and connective tissue proteins. Human gingival fibroblasts were cultured with cyclosporine A, and the expression of two vital endoplasmic stress markers and two prime matrix proteins (connective tissue growth factor (CTGF and periostin) were assessed by RT-PCR. We found that expression of Glucose-Regulated Protein 78 (GRP78/BIP) and CCAAT/enhancer binding protein, C/EBP homologous protein (CHOP) were significantly increased, along with CTGF and periostin, suggesting a role for these factors in gingival overgrowth.


Assuntos
Moléculas de Adesão Celular/genética , Fator de Crescimento do Tecido Conjuntivo/genética , Ciclosporina/efeitos adversos , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Proteínas de Choque Térmico/genética , Imunossupressores/efeitos adversos , Fator de Transcrição CHOP/genética , Biomarcadores/metabolismo , Moléculas de Adesão Celular/agonistas , Moléculas de Adesão Celular/metabolismo , Fator de Crescimento do Tecido Conjuntivo/agonistas , Fator de Crescimento do Tecido Conjuntivo/metabolismo , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/metabolismo , Chaperona BiP do Retículo Endoplasmático , Estresse do Retículo Endoplasmático/genética , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Regulação da Expressão Gênica , Gengiva/citologia , Gengiva/efeitos dos fármacos , Gengiva/metabolismo , Proteínas de Choque Térmico/agonistas , Proteínas de Choque Térmico/metabolismo , Humanos , Cultura Primária de Células , Transdução de Sinais , Fator de Transcrição CHOP/agonistas , Fator de Transcrição CHOP/metabolismo
2.
J Cardiovasc Pharmacol ; 67(2): 110-20, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26371948

RESUMO

Connective tissue growth factor (CTGF) is a fibrogenic cytokine that promotes fibrosis in various organs. In the heart, both cardiomyocytes (CM) and cardiac fibroblasts have been reported as a source of CTGF expression, aiding cardiac fibrosis. Although the mammalian target of rapamycin (mTOR) forms 2 distinct complexes, mTORC1 and mTORC2, and plays a central role in integrating biochemical signals for protein synthesis and cellular homeostasis, we explored its role in CTGF expression in adult feline CM. CM were stimulated with 10 µM phenylephrine (PE), 200 nM angiotensin (Ang), or 100 nM insulin for 24 hours. PE and Ang, but not insulin, caused an increase in CTGF mRNA expression with the highest expression observed with PE. Inhibition of mTOR with torin1 but not rapamycin significantly enhanced PE-stimulated CTGF expression. Furthermore, silencing of raptor and rictor using shRNA adenoviral vectors to suppress mTORC1 and mTORC2, respectively, or blocking phosphatidylinositol 3-kinase (PI3K) signaling with LY294002 (LY) or Akt signaling by dominant-negative Akt expression caused a substantial increase in PE-stimulated CTGF expression as measured by both mRNA and secreted protein levels. However, studies with dominant-negative delta isoform of protein kinase C demonstrate that delta isoform of protein kinase C is required for both agonist-induced CTGF expression and mTORC2/Akt-mediated CTGF suppression. Finally, PE-stimulated CTGF expression was accompanied with a corresponding increase in Smad3 phosphorylation and pretreatment of cells with SIS3, a Smad3 specific inhibitor, partially blocked the PE-stimulated CTGF expression. Therefore, a PI3K/mTOR/Akt axis plays a suppressive role on agonist-stimulated CTGF expression where the loss of this mechanism could be a contributing factor for the onset of cardiac fibrosis in the hypertrophying myocardium.


Assuntos
Fator de Crescimento do Tecido Conjuntivo/agonistas , Fator de Crescimento do Tecido Conjuntivo/biossíntese , Miócitos Cardíacos/metabolismo , Serina-Treonina Quinases TOR/biossíntese , Angiotensinas/farmacologia , Animais , Gatos , Células Cultivadas , Miócitos Cardíacos/efeitos dos fármacos , Fenilefrina/farmacologia
3.
Nat Commun ; 5: 5797, 2014 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-25504335

RESUMO

Systemic sclerosis (SSc) is manifested by fibrosis, vasculopathy and immune dysregulation. So far, a unifying hypothesis underpinning these pathological events remains unknown. Given that SSc is a multifactorial disease caused by both genetic and environmental factors, we focus on the two transcription factors, which modulate the fibrotic reaction and are epigenetically suppressed in SSc dermal fibroblasts, Friend leukaemia integration 1 (Fli1) and Krüppel-like factor 5 (KLF5). In addition to the Fli1 silencing-dependent collagen induction, the simultaneous knockdown of Fli1 and KLF5 synergistically enhances expression of connective tissue growth factor. Notably, mice with double heterozygous deficiency of Klf5 and Fli1 mimicking the epigenetic phenotype of SSc skin spontaneously recapitulate all the three features of SSc, including fibrosis and vasculopathy of the skin and lung, B-cell activation and autoantibody production. These studies implicate the epigenetic downregulation of Fli1 and KLF5 as a central event triggering the pathogenic triad of SSc.


Assuntos
Autoanticorpos/biossíntese , Linfócitos B/metabolismo , Fatores de Transcrição Kruppel-Like/genética , Proteína Proto-Oncogênica c-fli-1/genética , Escleroderma Sistêmico/genética , Pele/metabolismo , Animais , Autoimunidade , Linfócitos B/imunologia , Linfócitos B/patologia , Vasos Sanguíneos/imunologia , Vasos Sanguíneos/metabolismo , Vasos Sanguíneos/patologia , Estudos de Casos e Controles , Colágeno/agonistas , Colágeno/genética , Colágeno/imunologia , Fator de Crescimento do Tecido Conjuntivo/agonistas , Fator de Crescimento do Tecido Conjuntivo/genética , Fator de Crescimento do Tecido Conjuntivo/imunologia , Modelos Animais de Doenças , Epigênese Genética , Fibroblastos/imunologia , Fibroblastos/metabolismo , Fibroblastos/patologia , Fibrose , Humanos , Fatores de Transcrição Kruppel-Like/antagonistas & inibidores , Fatores de Transcrição Kruppel-Like/imunologia , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Ativação Linfocitária , Camundongos , Camundongos Transgênicos , Proteína Proto-Oncogênica c-fli-1/antagonistas & inibidores , Proteína Proto-Oncogênica c-fli-1/imunologia , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Escleroderma Sistêmico/imunologia , Escleroderma Sistêmico/metabolismo , Escleroderma Sistêmico/patologia , Transdução de Sinais , Pele/imunologia , Pele/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...